The fate of [35S]-phenothiazine, a veterinary anthelmintic, has been investigated in the adult male marmoset (Callithrix jacchus) following oral administration. A near complete recovery of radioactivity (c. 95%) was achieved in 0-3 days, with just over one-third of the dose (c. 37%) being present in the urine and the remainder (c. 58%) being accounted for in the faeces. The majority of the urinary radioactivity (c. 91%) was present as conjugates, tentatively identified as phenothiazine N-glucuronide and leucophenothiazone sulphate. Smaller amounts of phenothiazone, thionol, phenothiazine sulphoxide and unchanged phenothiazine were also identified. The only compound identified in the faeces was unchanged phenothiazine.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1515/dmdi.2009.24.2-4.137 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Biomarkers.
Alzheimers Dement
December 2024
University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Background: Studies of aging in non-human primates are important to elucidate primate-specific mechanisms underlying human aging, including pathological trajectories like Alzheimer's disease (AD). Evidence of AD-like brain aging has been reported across the primate order including amyloid beta (AB) deposits, but blood-based biomarkers are less well-studied. The goal of this project was to explore the use of validated assays for plasma biomarkers in two new non-human primate species: coppery titi monkeys (Plecturocebus cupreus) and brown capuchins (Sapajus apella).
View Article and Find Full Text PDFBiomarkers.
Alzheimers Dement
December 2024
University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Background: The common marmoset (Callithrix jacchus) is an important animal model in neuroscience and neurological diseases, presenting primate-specific evolutionary features such as an expanded frontal cortex. We established a new consortium with funding support from the National Institute on Aging to generate, characterize, and validate MArmosets as Research MOdels of AD (MARMO-AD). This consortium develops and studies gene-edited marmoset models carrying genetic risk for AD, comparing them against wild-type aging marmosets from birth throughout their lifespan, using non-invasive longitudinal assessments.
View Article and Find Full Text PDFBiomarkers.
Alzheimers Dement
December 2024
University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Background: The common marmoset (Callithrix jacchus) is an important animal model in neuroscience and neurological diseases (e.g., Alzheimer's disease - AD), as they present primate-specific evolutionary features such as an expanded frontal cortex.
View Article and Find Full Text PDFBiomarkers.
Alzheimers Dement
December 2024
University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Background: The common marmoset (Callithrix jacchus) is an important animal model in neuroscience and neurological diseases (e.g., Alzheimer's disease - AD), as they present primate-specific evolutionary features such as an expanded frontal cortex.
View Article and Find Full Text PDFBackground: Nonhuman primates are arguably the best models for Alzheimer's disease (AD), due to close similarities with humans in physiology and behavior, brain structure and function, and aging patterns. The common marmoset (Callithrix jacchus) is particularly valuable because it has the shortest lifespan of all anthropoids (10-12 years), exhibits sex differences in age-related cognitive decline and develops AD-like pathology with age. In the present study, we investigated blood-based biomarkers in male and female marmosets with cognitive and neuropathological assessments.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!